Clinical

Dataset Information

0

Pharmacogenomic Study for Individual Response to CPT-11 in Colorectal Cancer Patients (Step 2)


ABSTRACT: Interventions: Intravenous adminstration of CPT-11 100 mg/m2 on Days 1, 8, and 15, every 4 weeks Primary outcome(s): 1)Tumor response rate 2)Genotype-phenotype association (CYP3A4,CES1,2, UGT1A1, ABCG2, ABCB1, and ABCC1,2 vs toxicity), mutation -phenotype association (TOP1A, ABCG2 vs tumor response), and expression-phenotype association (TOP1A, ABCG2 vs tumor response) Study Design: Single arm Non-randomized

DISEASE(S): Stage Iv Colorectal Cancer After Palliative Operation

PROVIDER: 2609520 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 2119625 | ecrin-mdr-crc
| PRJNA343956 | ENA
| PRJNA575228 | ENA
| PRJNA714147 | ENA
| 2731919 | ecrin-mdr-crc
2024-04-24 | GSE264293 | GEO
2021-03-05 | GSE146448 | GEO
| 2620216 | ecrin-mdr-crc
| PRJNA1147393 | ENA
2010-05-26 | GSE19730 | GEO